Screener
Kiniksa Pharmaceuticals International, plc KNSA Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Kiniksa Pharmaceuticals International, plc’s reported figures.
The source filing: Kiniksa Pharmaceuticals International, plc’s 10-Q, filed July 28, 2026. Open the filing →
- Filed
- Jul 28, 2026, 4:17 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-087545
FAQ
- What is Kiniksa Pharmaceuticals International, plc's enterprise value?
- Kiniksa Pharmaceuticals International, plc (KNSA) reported enterprise value of $4.75B in Q2 2026.
- How has Kiniksa Pharmaceuticals International, plc's enterprise value changed year-over-year?
- Kiniksa Pharmaceuticals International, plc's enterprise value increased by 145.2% year-over-year, from $1.94B to $4.75B.
- What is the long-term trend for Kiniksa Pharmaceuticals International, plc's enterprise value?
- Over 5 years (2020 to 2025), Kiniksa Pharmaceuticals International, plc's enterprise value has grown at a 21.8% compound annual growth rate (CAGR), from $1.11B to $2.97B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.
Ask your AI about Kiniksa Pharmaceuticals International, plc's enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude